Elevated Capital Advisors’s Organon & Co OGN Stock Holding History

Elevated Capital Advisors’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$543	Hold	40	–	–	﹤0.01%	791
2026 Q1	$240	Hold	40	–	–	﹤0.01%	826
2025 Q4	$287	Buy	+40	New	+$316	﹤0.01%	798

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Elevated Capital Advisors's OGN Position: Q2 2026 in Review

Elevated Capital Advisors held its Organon & Co (OGN) position steady in Q2 2026 at 40 shares worth $543. The position accounts for ﹤0.01% of the portfolio, ranked #791.

Elevated Capital Advisors first reported a position in OGN in Q4 2025 and has held it in 3 quarters since. 635 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Elevated Capital Advisors held 40 shares of Organon & Co worth $543 as of Q2 2026.
Elevated Capital Advisors left its Organon & Co share count unchanged in Q2 2026.
Organon & Co made up ﹤0.01% of Elevated Capital Advisors's portfolio in Q2 2026, its #791 holding.
Elevated Capital Advisors first reported a position in Organon & Co in Q4 2025 and has held it in 3 quarters since.
635 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Elevated Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.